PATENT CLAIM ANALYSIS

Application Number: 15990486
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["424", "204100"]

Abstract:
Ligand-specific HVEM variants, compositions comprising such variants, and methods of treating inflammatory diseases comprising administering such variants, are provided.

Claim (Index 47):
An isolated recombinant herpesvirus entry mediator (HVEM) polypeptide variant, wherein the variant specifically binds BTLA and does not bind CD160, and wherein the variant comprises an amino acid substitution at residue position 59 from the starting methionine.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.35294
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13677703', '14175892', '13003191', '12482426', '11719356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7606472541614308
- 35 USC 102 Novelty (BERT): 0.650114186960867
- Combined Prediction Score: 0.7495939474413744
- Mean Citation Score: 461.712654
- Max Citation Score: 744.7695
- Similarity Product: 553.8308509220481

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test